SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001165527-18-000156
Filing Date
2018-07-25
Accepted
2018-07-24 18:11:04
Documents
40
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 g8597.htm 10-Q 385054
2 ex31.htm EX-31 13548
3 ex32.htm EX-32 4816
  Complete submission text file 0001165527-18-000156.txt   2146856

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT clcs-20170331.xml EX-101.INS 309511
5 XBRL TAXONOMY EXTENSION SCHEMA clcs-20170331.xsd EX-101.SCH 27210
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clcs-20170331_cal.xml EX-101.CAL 36710
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clcs-20170331_def.xml EX-101.DEF 110147
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE clcs-20170331_lab.xml EX-101.LAB 174315
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clcs-20170331_pre.xml EX-101.PRE 149145
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 18967286
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1